Sava Infond d.o.o.

Position in DXCM — Dexcom Inc

CIK 2055882 MARIBOR, 2A

Position in DXCM

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$481,889

-$29,931 QoQ

Shares Held

7,155

-12.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#579

of 966 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sava Infond d.o.o. holds $8,011,225 across 6 Medical Devices names. DXCM ranks #5 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	87,020	$3,714,012
2	ABT	Abbott Laboratories	23,550	$2,136,927
3	SYK	Stryker Corp	2,150	$676,906
4	MDT	Medtronic plc	8,350	$653,220
5	DXCM	Dexcom Inc This page	7,155	$481,889
6	EW	Edwards Lifesciences Corp	3,850	$348,271

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$481,889	7,155	-12.2%	Shares	Defined	2026-07-16
2026-03-31	$511,820	8,150	-14.7%	Shares	Defined	2026-05-11
2025-12-31	$633,833	9,550	+28.2%	Shares	Defined	2026-01-29
2025-09-30	$501,310	7,450	+22.1%	Shares	Sole	2025-11-10
2025-06-30	$532,469	6,100	0.0%	Shares	Sole	2025-07-22
2025-03-31	$416,569	6,100	0.0%	Shares	Sole	2025-04-23
2024-12-31	$474,397	6,100	—	Shares	Sole	2025-02-12
No filing history on record for this holder in this stock.